| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/20/2009 | CN101433725A Novel magnetic target gene transmission system and preparation thereof |
| 05/20/2009 | CN101433723A PH sensitivity type anticancer prodrug as well as preparation method and application thereof |
| 05/20/2009 | CN101433722A Fusions of cytokines and tumor targeting proteins |
| 05/20/2009 | CN101433721A Nimesulide-hydroxypropyl-beta-cyclodextrin inclusion compound eye drops and preparation method thereof |
| 05/20/2009 | CN101433720A Tumor-targeted carbon nano-tube medicament carrier and preparation thereof |
| 05/20/2009 | CN101433719A External-use substrate for skin |
| 05/20/2009 | CN101433718A Biodegradable polypeptide vesicle loaded with hemoglobin and preparation method thereof |
| 05/20/2009 | CN101433716A Composition for treating malignant solid tumors and preparation thereof and use |
| 05/20/2009 | CN101433714A Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 05/20/2009 | CN101433655A Chinese medicinal composition for treating colpitis |
| 05/20/2009 | CN101433654A Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof |
| 05/20/2009 | CN101433648A Rheumatism plastic and preparation method thereof |
| 05/20/2009 | CN101433610A Shan ju coated dispersible tablet for releasing pressure and preparation method thereof |
| 05/20/2009 | CN101433594A Sugar-free honeysuckle flower common cold granule |
| 05/20/2009 | CN101433588A Method for producing five-ester dropping pills |
| 05/20/2009 | CN101433579A Antivirus transdermal emulsifiable paste containing penciclovir, liquorice, astragalus, cassia nomame and basil |
| 05/20/2009 | CN101433568A Extraction of burdock root aqueous extract and use |
| 05/20/2009 | CN101433546A Capecitabine sustained and controlled release oral formulation and preparation method thereof |
| 05/20/2009 | CN101433537A External-use spray for resisting mycotic infection of superficial part and preparation method thereof |
| 05/20/2009 | CN101433533A Intravenous injection emulsion of paclitaxel or polyenic taxusol |
| 05/20/2009 | CN101433527A Use of plant capsule in powder spray |
| 05/20/2009 | CN101433526A Non-gelatine enteric hard capsule shell material and method for producing the same |
| 05/20/2009 | CN101433525A Method for preparing colon positioning compression-coated tablets |
| 05/20/2009 | CN101433521A Medicinal inhalable particles, pulmonary inhalation using the same and preparation method thereof |
| 05/20/2009 | CN101433520A Anticancer sustained-release agent containing epothilone |
| 05/20/2009 | CN101433515A High-efficient low-toxicity ultrasonic microvesicle for carrying ricin A chain and preparation method thereof |
| 05/20/2009 | CN101433514A Curcumin-poloxamer solid dispersion as well as preparation method and application thereof |
| 05/20/2009 | CN101433513A Semi-interpenetrating network polymer gel for oral colon-specific drug release system and preparation method thereof |
| 05/20/2009 | CN100489654C Laser projector |
| 05/20/2009 | CN100489102C T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 05/20/2009 | CN100488984C Reducing immunogenicity of fusion proteins |
| 05/20/2009 | CN100488980C Integrin binding motif containing peptides and its uses |
| 05/20/2009 | CN100488950C Use of chemotherapeutic agents |
| 05/20/2009 | CN100488763C System, method and apparatus for producing dosage forms |
| 05/20/2009 | CN100488566C Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant |
| 05/20/2009 | CN100488565C Pharmaceutical and cosmetic formulation |
| 05/20/2009 | CN100488563C Modified anti-EGFR antibody with reduced immunogenicity |
| 05/20/2009 | CN100488562C Clotting factor VII or VIIa like molecules |
| 05/20/2009 | CN100488560C Method for preparing mass micro-capsule |
| 05/20/2009 | CN100488517C Composition for trapping and inactivating pathogenic microbes and spermatozoa and its pharmaceutical uses |
| 05/20/2009 | CN100488515C Ground erythromycin enteric micropill and its preparation method |
| 05/20/2009 | CN100488512C Compositions for treatment of cell proliferative disorders and its uses |
| 05/20/2009 | CN100488507C Dosage form containing pantoprazole as active ingredient |
| 05/20/2009 | CN100488502C Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs |
| 05/20/2009 | CN100488499C Orally disintegrating tablet of coenzyme Q10 and preparation method thereof |
| 05/19/2009 | US7534915 Non-symmetrical gelling agent |
| 05/19/2009 | US7534870 Stable pharmaceutical composition comprising erythropoietin |
| 05/19/2009 | US7534862 Polypeptide-dimers for use in treatment and prevention of infection, bone, blood, eating, tumor, autoimmune and inflammatory disorders |
| 05/19/2009 | US7534819 Compositions and methods for intracellular delivery of biotinylated cargo |
| 05/19/2009 | US7534613 Methods of treating parkinson's disease using viral vectors |
| 05/19/2009 | US7534603 Fusion protein delivery system and uses thereof |
| 05/19/2009 | US7534450 Promoting metallothioneins by administering a copper-free nutrient supplement containing 50 - 150 mg of zinc, and further containing vitamin B6, pyridoxal-5'-phosphate, vitamin E, vitamin A, vitamin C, selenium, glutathione, taurine, and a mixture of amino acids |
| 05/19/2009 | US7534443 Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient |
| 05/19/2009 | US7534441 Immunogenic LHRH compositions and methods relating thereto |
| 05/19/2009 | US7534431 Targetting antibodies containing haptens, cleaning agent, and drug delivery agent; tissue-directed therapy; solid phase synthesis |
| 05/19/2009 | US7534424 Optimizing the dosage of a therapeutic nucleic acid by using doxorubicin which is known to deplete liver macrophages known as Kupffer cells, thereby reducing liver toxicity |
| 05/19/2009 | CA2591917C Analgesic compositions for treating painful conditions of the anal region and uses thereof |
| 05/19/2009 | CA2585691C Enhanced bimatoprost ophthalmic solution |
| 05/19/2009 | CA2463947C Montelukast granule formulation |
| 05/19/2009 | CA2458872C Human ubiquitin-conjugating enzyme |
| 05/19/2009 | CA2401766C Lipid nanocapsules, preparation method and use as medicine |
| 05/19/2009 | CA2387247C Use of neutralizing agents to growth factors for reducing wound scarring |
| 05/19/2009 | CA2386685C Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases |
| 05/19/2009 | CA2374629C Film coatings and film coating compositions based on polyvinyl alcohol |
| 05/19/2009 | CA2360102C Tablets disintegrating rapidly in the oral cavity |
| 05/19/2009 | CA2352542C Method for producing medicaments from plant extracts, in a solid form of administration |
| 05/19/2009 | CA2345024C Modified tgf-.beta. superfamily proteins |
| 05/19/2009 | CA2338651C Pyrrolo[2,1-b][1,3]benzothiazepines with atypical antipsychotic activity |
| 05/19/2009 | CA2333680C Semi-solid aqueous preparations for oral applications of toltrazuril sulphone |
| 05/19/2009 | CA2316060C Underwater pelletizing of active-compound-containing melts |
| 05/19/2009 | CA2312004C Site-specific preparation of polyethylene glycol-grf conjugates |
| 05/19/2009 | CA2276164C Injectable implant |
| 05/19/2009 | CA2210891C Valaciclovir tablets containing colloidal silicon dioxide |
| 05/19/2009 | CA2206657C Therapeutic preparation for inhalation containing parathyroid hormone, pth |
| 05/19/2009 | CA2163716C Verotoxin pharmaceutical compositions and medical treatments therewith |
| 05/14/2009 | WO2009062136A2 Controlled delivery of insulin from thermo-sensitive polymer solution |
| 05/14/2009 | WO2009062100A1 Modified recombinant factor viii and von willebrand factor and methods of use |
| 05/14/2009 | WO2009061607A2 Water-immiscible materials as vehicles for drug delivery |
| 05/14/2009 | WO2009061473A2 Photonic shell-core cross linked and functionalized nanostructures for biological applications |
| 05/14/2009 | WO2009061298A1 Topical treatment with dapsone in g6pd-deficient patients |
| 05/14/2009 | WO2009061273A1 Dry powder formulations comprising ascorbic acid derivates |
| 05/14/2009 | WO2009061003A2 Nucleic acid complex and nucleic acid delivery composition |
| 05/14/2009 | WO2009060952A1 Novel preparation |
| 05/14/2009 | WO2009060915A1 Salivary secretion promoter |
| 05/14/2009 | WO2009060857A1 Method for producing membrane protein |
| 05/14/2009 | WO2009060710A1 Peptide imparting antibody-binding ability to liposome and liposome modified with the same |
| 05/14/2009 | WO2009060629A1 Lidocaine tape preparation |
| 05/14/2009 | WO2009060609A1 Method for producing microcapsule using solid fat |
| 05/14/2009 | WO2009060608A1 Sustained release composition containing sdf-1 |
| 05/14/2009 | WO2009060473A2 Injectable compositions, processes and uses thereof |
| 05/14/2009 | WO2009060226A1 Intranasal compositions |
| 05/14/2009 | WO2009060218A1 Novel complexes and a process for their preparation |
| 05/14/2009 | WO2009060086A2 Increase of immune response and targeting by antigens and/or drug linkage |
| 05/14/2009 | WO2009059989A1 Aqueous emulsions comprising a hydrophobic active ingredient |
| 05/14/2009 | WO2009059984A2 Reversible hydrophobization of antitumor drugs for enhanced first-pass drug uptake |
| 05/14/2009 | WO2009059784A1 Biocompatible three dimensional matrix for the immobilization of biological substances |
| 05/14/2009 | WO2009059755A2 Novel neurturin conjugates for pharmaceutical use |
| 05/14/2009 | WO2009059748A2 Compositions for the topical protection of the ocular tissues from the damaging effects of ultraviolet radiations |
| 05/14/2009 | WO2009059717A2 Pharmaceutical compositions containing statins and omega-3 fatty acids derivatives and their solid formulations for oral use |
| 05/14/2009 | WO2009059510A1 Ph-sensitive solid pharmaceutical composition for oral formulation and preparation method thereof |